ArticleImmunologic research2024
The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells.
Maryam Soltani-Asl et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it